The use of a clindamycin 1%-benzoyl peroxide 5% topical gel in the treatment of pitted keratolysis: a novel therapy.
Vlahovic
Tracey C
TC
Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania, USA.
Dunn
Sean P
SP
Kemp
Kenneth
K
D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001585:Benzoyl Peroxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005533:Foot Dermatoses / Q000188:drug therapy* / Q000382:microbiology; D005782:Gels; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D006945:Hyperhidrosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D011379:Prognosis; D011446:Prospective Studies
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D005782:Gels; D002981:Clindamycin; D001585:Benzoyl Peroxide